Largest pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by earnings, at DKK 182.6B, ahead of Eli Lilly (DKK 140.6B) and Merck & Co (DKK 124.3B). Figures as of 18 Nov 2026, 20:24 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonDKK 182.6B
- Median
- DKK 401.9M
- Combined market value
- DKK 34.56T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | DKK 182.6B | DKK 4.49T | DKK 1,865.12 | 1.75% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | DKK 140.6B | DKK 8.42T | DKK 9,453.48 | 1.96% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | DKK 124.3B | DKK 2.33T | DKK 943.67 | 3.37% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | DKK 103.5B | DKK 1.18T | DKK 268.71 | 3.07% down | 17% down | ||
| 5 | NovartisNVS · Health Care | DKK 95.3B | DKK 2T | DKK 1,057.28 | 2.46% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | DKK 69.6B | DKK 1.89T | DKK 1,220.04 | 1.73% down | 2% up | ||
| 7 | SanofiSNY · Health Care | DKK 59B | DKK 771.8B | DKK 321.40 | 0.73% down | 4% down | ||
| 8 | PfizerPFE · Health Care | DKK 52.9B | DKK 1.09T | DKK 191.57 | 1.21% down | 14% up | ||
| 9 | GSKGSK · Health Care | DKK 51.7B | DKK 665.3B | DKK 331.92 | 1.04% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | DKK 48B | DKK 834.8B | DKK 408.42 | 2.27% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | DKK 44.4B | DKK 1.24T | DKK 715.14 | 0.27% up | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | DKK 30.7B | DKK 667.1B | DKK 6,448.24 | 1.16% down | 36% up | ||
| 13 | AbbVieABBV · Health Care | DKK 28.8B | DKK 3.45T | DKK 1,952.24 | 2.12% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | DKK 26.9B | DKK 929.4B | DKK 3,665.57 | 0.74% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | DKK 18.2B | DKK 239.2B | DKK 588.58 | 3.51% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 9.6B | DKK 335.1B | DKK 287.21 | 1.07% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | DKK 9.1B | DKK 168.2B | DKK 3,949.58 | 0.73% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | DKK 6.6B | DKK 214.8B | DKK 348.41 | 1.56% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | DKK 5.3B | DKK 270.7B | DKK 470.71 | 0.62% up | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | DKK 4.6B | DKK 34.2B | DKK 409.34 | 0.44% down | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 3.1B | DKK 85.2B | DKK 102.24 | 1.49% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | DKK 3B | DKK 67.9B | DKK 449.56 | 5.25% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | DKK 3B | DKK 39.2B | DKK 57.56 | 2.09% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | DKK 2.4B | DKK 80.9B | DKK 417.89 | 4.85% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | DKK 2.1B | DKK 136.4B | DKK 1,018.22 | 4.48% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | DKK 2B | DKK 314.1B | DKK 2,749.60 | 2.32% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | DKK 1.6B | DKK 53.3B | DKK 317.08 | 2.42% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | DKK 847.7M | DKK 40.7B | DKK 2,032.96 | 1.58% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | DKK 678.8M | DKK 50.7B | DKK 463.39 | 2.91% down | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | DKK 490.8M | DKK 51.7B | DKK 148.46 | 3.20% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 401.9M | DKK 50.8B | DKK 647.09 | 0.12% down | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -DKK 11.1M | DKK 41.8B | DKK 295.35 | 0.86% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -DKK 159.1M | DKK 41.1B | DKK 629.45 | 0.50% up | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -DKK 174M | DKK 33B | DKK 344.05 | 1.15% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -DKK 476.8M | DKK 35.8B | DKK 848.88 | 0.81% down | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -DKK 528.6M | DKK 43.2B | DKK 1,063.89 | 0.97% down | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -DKK 718.2M | DKK 44.3B | DKK 652.47 | 0.55% down | 241% up | ||
| 38 | ErascaERAS · Health Care | -DKK 848.3M | DKK 32.5B | DKK 92.57 | 2.16% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -DKK 886.5M | DKK 56.3B | DKK 862.34 | 1.55% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -DKK 1.1B | DKK 65.2B | DKK 686.39 | 7.42% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -DKK 1.1B | DKK 32.6B | DKK 579.11 | 2.25% down | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -DKK 1.1B | DKK 31B | DKK 282.81 | 1.24% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -DKK 1.2B | DKK 48.1B | DKK 913.80 | 1.32% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -DKK 1.3B | DKK 26.9B | DKK 196.34 | 1.89% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -DKK 1.3B | DKK 56.1B | DKK 809.61 | 1.93% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -DKK 1.6B | DKK 91.6B | DKK 183.20 | 4.04% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -DKK 1.7B | DKK 121.1B | DKK 1,845.95 | 0.07% down | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -DKK 2B | DKK 63.1B | DKK 2,714.86 | 5.55% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -DKK 2B | DKK 21.4B | DKK 110.55 | 0.74% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -DKK 2B | DKK 190.6B | DKK 263.03 | 0.25% down | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -DKK 2.1B | DKK 58.5B | DKK 2,094.26 | 0.79% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -DKK 2.2B | DKK 33.3B | DKK 191.54 | 0.97% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -DKK 2.4B | DKK 107.8B | DKK 1,679.61 | 2.44% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -DKK 2.5B | DKK 49.8B | DKK 569.13 | 1.77% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -DKK 2.6B | DKK 31.5B | DKK 188.85 | 2.84% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -DKK 5B | DKK 103.4B | DKK 530.62 | 1.43% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -DKK 5.3B | DKK 49B | DKK 351.54 | 0.08% down | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -DKK 6.5B | DKK 463.4B | DKK 145.05 | 1.59% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -DKK 7.4B | DKK 57.3B | DKK 71.59 | 1.50% down | 36% down | ||
| 60 | InsmedINSM · Health Care | -DKK 8.7B | DKK 179.1B | DKK 816.19 | 1.67% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -DKK 23.9B | DKK 159.7B | DKK 139.33 | 0.02% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8115 DKK).
Questions and answers
Which pharmaceutical companies rank first by earnings?
Johnson & Johnson (DKK 182.6B), Eli Lilly (DKK 140.6B) and Merck & Co (DKK 124.3B) are the top three of the 61 pharmaceutical companies ranked by earnings as of 18 Nov 2026, 20:24 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by earnings have a combined market value of DKK 34.56T as of 18 Nov 2026, 20:24 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.